SCHEMBL6748002

SCHEMBL6748002

N#Cc1ncc(C(F)(F)F)cc1S[C@H](C[C@H](N)CO)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
CYP2D6 P10635 2/20 0.35
SLC6A2 P23975 2/20 0.35
SLC6A4 P31645 2/20 0.35
NOS2 P35228 2/20 0.35
GAA P10253 2/20 0.35
HTT P42858 1/20 0.33
MPO P05164 1/20 0.32
ALOX5AP P20292 1/20 0.32
PKM P14618 1/20 0.31
AR P10275 4/20 0.31
TRPM8 Q7Z2W7 1/20 0.31
PTGS1 P23219 1/20 0.31
PTGS2 P35354 1/20 0.31
PNMT P11086 1/20 0.30
PGR P06401 1/20 0.30
FFAR4 Q5NUL3 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6185724 0.84 CYP2D6 (0.35) ALDH1A1SMN1; SMN2CYP2D6SLC6A2SLC6A4
SCHEMBL6186368 0.84 CYP2D6 (0.44) ALDH1A1SMN1; SMN2CYP2D6SLC6A2SLC6A4
SCHEMBL6189779 0.76 CYP3A4 (0.36) CYP2D6SLC6A2SLC6A4NOS2ALOX5AP
Hydrochloric Acid SCHEMBL6748191 0.75 CYP3A4 (0.36) CYP2D6SLC6A2SLC6A4NOS2ALOX5AP
SCHEMBL6750954 0.74 CYP2D6 (0.42) ALDH1A1CYP2D6SLC6A2SLC6A4NOS2
SCHEMBL6188753 0.74 CYP2D6 (0.42) ALDH1A1SMN1; SMN2MEN1KMT2ACYP2D6
SCHEMBL6748041 0.72 CYP2D6 (0.39) ALDH1A1CYP2D6SLC6A2SLC6A4NOS2
SCHEMBL6185529 0.71 CYP2D6 (0.40) ALDH1A1KMT2ACYP2D6SLC6A2SLC6A4
SCHEMBL6746295 0.71 CYP2D6 (0.40) ALDH1A1KMT2ACYP2D6SLC6A2SLC6A4
SCHEMBL231181 0.71 CYP2D6 (0.40) ALDH1A1KMT2ACYP2D6SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040242871-A1 Novel arylheteroalkylamine derivatives ASTRAZENECA AB (SE) 2004-12-02 US claimed
US-20040242871-A1 Novel arylheteroalkylamine derivatives ASTRAZENECA AB (SE) 2004-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040242871-A1 Novel arylheteroalkylamine derivatives CYP1A1, NOS3, NOS1 ALDH1A1 495/4885SMN1; SMN2 3507/4885MEN1 4748/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.